Artificial Intelligence

The health system is piloting new tools to streamline workflows, such an ambient listening during patient exams, says Albert Marinez, its chief analytics officer. He describes some lessons learned during early-stage implementation.  

"The intersection of public health and artificial intelligence represents a transformation in healthcare," says one epidemiologist, who sees the chance to greatly improve disease prevention and management, and promote health and wellness.

With guidelines and rules for healthcare AI coming from the FDA, ONC, OCR, the White House and others, how will this regulatory framework change in 2024? Bryant Godfrey, partner at Foley Hoag, offers some thoughts.  

Regulators are starting to see an opportunity to incentivize the use of artificial intelligence and machine learning, says one expert, who predicts accelerating adoption ahead, with "meaningful use" of explainable AI.

The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise been undetected.

Tech-enabled experiential learning is elevating nursing curriculums to engage more students – and produce more graduates who say they're ready to hit the ground running in a digital health environment.

For all its potential benefits for healthcare, it's still critical to understand how patient data is being collected and used for AI models, says Sara Shanti, a partner in Sheppard Mullin's Chicago-based Corporate Practice Group.

Andreessen Horowitz investment partner Jay Rughani discusses the paper he and his colleagues published recently about clinical use cases of AI, and outlined steps regulators should take for reimbursing providers using the technology.

The technology falsely tagged consumers, particularly women and people of color, as shoplifters, FTC says.

A new law passed in New York and legislation introduced in Ohio are just two of the latest examples of a legislative push to expand insurance coverage for biomarker testing.